MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF STELLENBOSCH on March 14, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF STELLENBOSCH on March 14, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF STELLENBOSCH on March 14, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF STELLENBOSCH on March 14, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF STELLENBOSCH on March 14, 2013. For personal use only. No other uses without permission. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Glutamate and aspartate are decreased in the skin in amyotrophic lateral sclerosis.
Nerve growth factor receptor immunostaining in the spinal cord and peripheral nerves in amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord.
Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis.
Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis.
TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord.
Spatial elucidation of spinal cord lipid- and metabolite- regulations in amyotrophic lateral sclerosis.
Lateral Sclerosis of the Spinal Cord.
Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients.
Excitatory amino acid receptors in human spinal cord. Evaluation in amyotrophic lateral sclerosis patients.
Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells.
Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis.
CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.
Mutant SOD1 inhibits ER-Golgi transport in amyotrophic lateral sclerosis.
Gem depletion: amyotrophic lateral sclerosis and spinal muscular atrophy crossover.
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis.
[Neuroinflammation in amyotrophic lateral sclerosis].
Amyotrophic lateral sclerosis.
Acceptance of brain-computer interfaces in amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis.
Brain-computer interfaces in amyotrophic lateral sclerosis: A metanalysis.
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis (ALS) is a chronic degenerative neurologic disorder characterized by the death of motor neurons in the cerebral cortex a...
932KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Glutamate and aspartate are decreased in the skin in amyotrophic lateral sclerosis.
Nerve growth factor receptor immunostaining in the spinal cord and peripheral nerves in amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord.
Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis.
Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis.
TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord.
Spatial elucidation of spinal cord lipid- and metabolite- regulations in amyotrophic lateral sclerosis.
Lateral Sclerosis of the Spinal Cord.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms